The prognostic value of a combined immune score in tumor and immune cells assessed by immunohistochemistry in triple-negative breast cancer

BACKGROUND: This study aimed to develop a novel combined immune score (CIS)-based model assessing prognosis in triple-negative breast cancer (TNBC). METHODS: The expression of eight immune markers (PD-1, PD-L1, PD-L2, IDO, TIM3, OX40, OX40L, and H7-H2) was assessed with immunohistochemistry on the t...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Ji Eun, Lee, Jae Seok, Jin, Min-Sun, Nikas, Ilias P., Kim, Kwangsoo, Yang, Sunah, Park, Soo Young, Koh, Jiwon, Yang, Sohyeon, Im, Seock-Ah, Ryu, Han Suk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625207/
https://www.ncbi.nlm.nih.gov/pubmed/37924153
http://dx.doi.org/10.1186/s13058-023-01710-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625207/
https://www.ncbi.nlm.nih.gov/pubmed/37924153
http://dx.doi.org/10.1186/s13058-023-01710-8

Ejemplares similares